Future clinical and biochemical predictions of Fabry disease in females by methylation studies of the GLA gene
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of α-galactosidase A (α-gal A). The clinical variability of the phenotypes of Fabry disease in females is still poorly understood. The degree of aberrant methylation of non-mutated alleles is thought to have significant e...
Main Authors: | Mohammad Arif Hossain, Chen Wu, Hiroko Yanagisawa, Takashi Miyajima, Keiko Akiyama, Yoshikatsu Eto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426919300795 |
Similar Items
-
Ten-year-long enzyme replacement therapy shows a poor effect in alleviating giant leg ulcers in a male with Fabry disease
by: Jun Okada, et al.
Published: (2018-03-01) -
Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy
by: Chen Wu, et al.
Published: (2017-09-01) -
Functional evaluation of a novel GLA causative mutation in Fabry disease
by: Ping Li, et al.
Published: (2019-09-01) -
Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease
by: Patrícia Varela, et al.
Published: (2019-09-01) -
A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS.
by: Chen Wu, et al.
Published: (2020-01-01)